The AJMC® Parkinson Disease compendium is a comprehensive resource for clinical news and expert insights for progressive nervous system disorder, which affects movement and often includes tremors.
February 26th 2025
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
Challenges, Advice for Caregivers of Patients With Parkinson Disease Experiencing Psychosis
February 26th 2021Among caregivers of patients with Parkinson disease experiencing psychosis, only 11% learned about the symptom from a physician, with communication challenges attributed to having to prioritize other issues in a limited appointment time.
Read More
Assessing Impact of Levodopa Responsiveness on DBS Efficacy in Parkinson Disease
February 23rd 2021Patients with levodopa-responsive and levodopa-resistant tremors exhibit differing preferences on the type of deep brain stimulation administered to control motor function in Parkinson disease.
Read More
Eye Test May Predict Parkinson-Related Cognitive Decline 18 Months Before Onset
February 20th 2021Visual dysfunction among patients with Parkinson disease was associated with worse cognitive performance after 18 months and a higher risk of developing mild cognitive impairment compared with those with normal vision.
Read More
Apple Watch Effective in Monitoring Symptoms of Parkinson Disease
February 8th 2021An Apple Watch designed to remotely monitor fluctuations of resting tremor and dyskinesia in persons with Parkinson disease was shown to match in-clinic evaluations of these symptoms and capture symptom changes in response to treatment for 94% of participants.
Read More
Changes in Blood Pressure, Cholesterol Levels May Predate Motor Symptoms in Parkinson Disease
January 26th 2021Changes in blood pressure, percentage of red blood cells, and serum cholesterol levels were found to occur in patients with Parkinson disease before the onset of motor symptoms, suggesting potential biomarkers for early diagnosis and treatment.
Read More
How Mutations in the Parkin Gene Affect Quality of Life in Patients With Parkinson Disease
January 4th 2021Patients with newly diagnosed Parkinson disease (PD) who carried mutations in the Parkin gene were found to exhibit worse quality of life, longer disease duration, and an earlier age at disease onset than those with PD who did not carry the mutation.
Read More
Top 5 Most-Read Parkinson Disease Articles of 2020
December 31st 2020The top 5 most-read Parkinson disease stories of 2020 on AJMC.com included the latest insights on treatments such as spinal cord stimulation and the role of dietary management, as well as implications of the coronavirus disease 2019 pandemic.
Read More
How Does Presence of Essential Tremor Affect Progression of Parkinson Disease?
December 24th 2020Among patients with Parkinson disease, a positive history of essential tremor was found to be associated with slower progression of motor and nonmotor symptoms, with no impact observed on survival.
Read More
How Has Neurological Telemedicine Fared Amid COVID-19?
December 8th 2020The effectiveness of telemedicine services among patients with neurological conditions was spotlighted amid the coronavirus disease 2019 (COVID-19) pandemic, particularly how telephone and video consultations have fared in temporarily replacing face-to-face consultations.
Read More
Machine Learning Approach May Offer Future Diagnostic Advances in Parkinson Disease
November 16th 2020A machine learning approach that works to identify mitochondrial impairments, a potential mechanism underlying the pathogenesis of Parkinson disease (PD), accurately distinguished between patients with PD and healthy controls.
Read More
How Tremor Affects Learning Abilities in Patients With Parkinson Disease
November 13th 2020Patients with Parkinson disease (PD) who do not experience tremor were found to show improvements in reward learning after taking dopaminergic medication, while those with PD and tremor exhibited no benefit in reinforcement learning.
Read More
How Socioeconomic Status Influences Mortality Risk in Patients With Parkinson Disease
November 6th 2020Individual-level low socioeconomic status (SES) was found to be significantly associated with increased mortality in Korean patients with Parkinson disease, whereas regional-level SES was not.
Read More
Skin Samples May Improve Earlier Diagnosis of Parkinson Disease
October 27th 2020A skin test to detect clumping of alpha-synuclein, an abnormal protein suggested to have a central role in the pathogenesis of Parkinson disease, may assist in improving earlier detection of the condition, according to study findings.
Read More
Air Pollution Tied to Higher Hospitalization Risk for PD, Other Neurological Disorders
October 20th 2020Air pollution was found to be significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson disease, Alzheimer disease, and other dementias.
Read More